To the best of our knowledge, this study is the first to conduct a comprehensive and systematic pan-cancer analysis of ABCA10 and ABCB5, exploring their correlations with immune cell infiltration and drug responses across multiple cancer types utilizing advanced multiomics tools. The gene discussed is ABCB5; the disease is cancer.